Discover AbbVie's strong performance, with immunology growth and undervaluation despite challenges. Click here to read an ...

AbbVie (NYSE:ABBV) has been actively advancing its oncology portfolio with recent presentations at the AACR Annual Meeting, ...

AbbVie has picked up another indication for its JAK inhibitor Rinvoq in the EU, becoming the first approved oral therapy for ...

AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” first quarter 2025 ...

communities and shareholders who depend on us." Miles D. White, chairman and chief executive officer, Abbott, in a press release from the 2nd January 2013. According to AbbVie, the company has ...

When US President Donald Trump slapped bigger-than-expected tariffs on imports from around the world, Americans lamented ...

Pharma tariffs could crush wages, sparking an HR crisis. How the US drug import tax and US pharma levies hit your workforce ...

The EU executive and top pharmaceutical companies shared a video call to address concerns over potential US tariffs on drugs ...

Ironwood Pharmaceuticals (IRWD) is undergoing a challenging transition with LINZESS but has promising growth potential with ...